Excelra

Excelra, founded in 2014 and headquartered in Hyderabad, India, is a global data science and analytics company specializing in life sciences.

Reviewed by 7wData
Share Email

On this page

Profile

Excelra provides data science and analytics solutions to accelerate drug discovery and development in the life sciences industry.

Excelra, founded in 2014 and headquartered in Hyderabad, India, is a global data science and analytics company specializing in life sciences. The company was established with the vision of transforming life science data into actionable insights for R&D clients, leveraging big data technology and analytics. Anandbir Singh Brar, who joined Excelra in 2014 and became CEO in 2016, has been instrumental in steering the company towards its current focus on bioinformatics, computational biology, and AI-driven drug discovery.

Excelra’s offerings span the entire pharma R&D value chain, from discovery to market, and include data structuring, analytics, and engineering services. The company has built a reputation for its ability to unify data from disparate sources and employ high-end data analytics to build predictive models, accelerating drug research and development. Excelra’s client base includes leading pharmaceutical companies and biotech firms, and it has partnered with organizations like Silexon AI Technology to enhance AI-driven drug discovery platforms.

The company’s financial trajectory has been positive, with a growing R&D BIO-IT team and expansion into clinical pharmacology and value evidence areas. Excelra’s recent focus has been on cloud-native platforms and AI/ML-driven solutions, aiming to streamline drug discovery workflows and improve efficiency.

Track Excelra and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Pharmaceutical companies
  • Biotech firms
  • Research institutions
  • Clinical research organizations (CROs)
  • Academic institutions

Publicly disclosed clients

  • Silexon AI Technology

Strengths and what to watch

Strengths

  • Deep domain expertise in life sciences and data engineering
  • Seamless unification of data from disparate sources
  • Strong focus on AI-driven drug discovery and cloud-native platforms

Watch for

  • High dependency on AI and machine learning technologies
  • Potential challenges in scaling operations globally
  • Competition from other data science and analytics providers

Key Information

Founded
2014
Headquarters
Hyderabad, India

Frequently Asked Questions

What does Excelra do?

Excelra provides data science and analytics solutions to accelerate drug discovery and development in the life sciences industry. Founded in 2014, the company focuses on transforming life science data into actionable insights using big data technology and AI-driven approaches.

How does Excelra use AI in drug discovery?

Excelra leverages AI and machine learning to streamline drug discovery workflows. Their AI-driven solutions include predictive modeling and data unification from disparate sources, enhancing efficiency and accelerating the R&D process for pharmaceutical and biotech clients.

What are Excelra's cloud-native platforms?

Excelra’s cloud-native platforms are designed to optimize drug discovery workflows. These platforms integrate AI and machine learning to improve efficiency, enabling seamless data management and analysis for life sciences R&D clients.

Who are Excelra's main clients?

Excelra primarily serves pharmaceutical companies, biotech firms, research institutions, clinical research organizations (CROs), and academic institutions. Notable clients include Silexon AI Technology, with whom Excelra collaborates on AI-driven drug discovery platforms.

What makes Excelra unique in data analytics?

Excelra stands out for its ability to unify data from disparate sources and apply advanced analytics. Their deep domain expertise in life sciences and focus on AI-driven solutions enable them to deliver actionable insights that accelerate drug discovery and development.

How does Excelra support the pharma R&D value chain?

Excelra supports the entire pharma R&D value chain, from discovery to market. Their services include data structuring, analytics, and engineering, helping clients streamline workflows, improve efficiency, and accelerate drug development through AI and cloud-native solutions.

Sources

  1. www.excelra.com — Anandbir Singh Brar’s role and Excelra’s vision
  2. www.excelra.com — Partnership with Silexon AI Technology
  3. www.excelra.com — Case study on cloud-native drug discovery platform
  4. www.excelra.com — Excelra’s solutions for the biopharma industry